Imc Chicago, LLC Viatris Inc Transaction History

Imc Chicago, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$9.2 - $12.26 $1.31 Million - $1.75 Million	-142,415 Closed	0 $0
Q4 2022 Feb 09, 2023	BUY	$8.72 - $11.56 $805,806 - $1.07 Million	92,409 Added 184.8%	142,415 $1.59 Million
Q3 2022 Nov 08, 2022	BUY	$8.48 - $11.13 $424,050 - $556,566	50,006 New	50,006 $426,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $291,858 - $398,165	-21,476 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$14.3 - $18.74 $307,106 - $402,460	21,476 New	21,476 $402,000

1,094

945M

3.49M

2.6M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

Stay updated on Imc Chicago, LLC with notifications on news.